JPH05320141A - 4,5-dihalogeno-6-@(3754/24)alpha-substituted-ethyl)pyrimidine and its production - Google Patents

4,5-dihalogeno-6-@(3754/24)alpha-substituted-ethyl)pyrimidine and its production

Info

Publication number
JPH05320141A
JPH05320141A JP16528692A JP16528692A JPH05320141A JP H05320141 A JPH05320141 A JP H05320141A JP 16528692 A JP16528692 A JP 16528692A JP 16528692 A JP16528692 A JP 16528692A JP H05320141 A JPH05320141 A JP H05320141A
Authority
JP
Japan
Prior art keywords
formula
compound
pyrimidine
dihalogeno
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP16528692A
Other languages
Japanese (ja)
Other versions
JP2649122B2 (en
Inventor
Katsutoshi Fujii
勝利 藤井
Yasushi Nakamoto
泰 中本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ube Corp
Original Assignee
Ube Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ube Industries Ltd filed Critical Ube Industries Ltd
Priority to JP16528692A priority Critical patent/JP2649122B2/en
Publication of JPH05320141A publication Critical patent/JPH05320141A/en
Application granted granted Critical
Publication of JP2649122B2 publication Critical patent/JP2649122B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PURPOSE:To provide a new 4,5-dihalogeno-6-(alpha-substituted-ethyl)pyrimidine useful as a synthetic intermediate for pharmaceuticals, agricultural chemicals, etc. CONSTITUTION:The compound of formula I (R is lower acyloxy or OH), e.g. 6-(alpha-acetoxyethyl)-4,5-dichloropyrimidine. The compound of formula I wherein R is lower acyloxy can be produced by reacting a pyrimidine compound of formula II with a lower aliphatic carboxylic acid of formula III (R' is lower alkyl) preferably in the presence of a base in a solvent. The obtained compound can be converted to another compound of formula I wherein R is OH by reacting with an inorganic salt of the formula M-OH (M is alkali metal).

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、医農薬などの合成中間
体として有用である新規な4,5−ジハロゲノ−6−
(α−置換エチル)ピリミジンに関するものである。
The present invention relates to a novel 4,5-dihalogeno-6-, which is useful as a synthetic intermediate for medicines and agricultural chemicals.
It relates to (α-substituted ethyl) pyrimidine.

【0002】[0002]

【従来技術の説明】医農薬などの合成中間体として有用
であるハロゲノピリミジン化合物は数多く知られている
(例えば、特開昭59−89670号公報など。)。し
かしながら、殺虫,殺ダニ,殺菌活性を有するピリミジ
ン誘導体(例えば、特願平3−354223号に記載の
化合物など)の合成原料として有用である本発明化合物
のような4,5−ジハロゲノ−6−(α−置換エチル)
ピリミジンについての報告は、認められない。
Description of the Prior Art Many halogenopyrimidine compounds useful as synthetic intermediates for medicines and agricultural chemicals are known (for example, JP-A-59-89670). However, 4,5-dihalogeno-6-like compounds of the present invention which are useful as raw materials for the synthesis of pyrimidine derivatives having insecticidal, acaricidal and bactericidal activities (for example, the compounds described in Japanese Patent Application No. 3-354223). (Α-substituted ethyl)
Reports on pyrimidines are not accepted.

【0003】[0003]

【発明が解決すべき課題】本発明の目的は、医農薬など
の合成中間体として有用である新規な4,5−ジハロゲ
ノ−6−(α−置換エチル)ピリミジンを提供すること
である。
DISCLOSURE OF THE INVENTION An object of the present invention is to provide a novel 4,5-dihalogeno-6- (α-substituted ethyl) pyrimidine which is useful as a synthetic intermediate for medicines and agricultural chemicals.

【0004】[0004]

【課題を解決するための手段】本発明者らは、前記の課
題を解決するために鋭意研究した結果、新規な4,5−
ジハロゲノ−6−(α−置換エチル)ピリミジンを合成
する方法を見出し、本発明を完成するに至った。即ち、
本発明は次の通りである。第1の発明は、次式(I):
Means for Solving the Problems The inventors of the present invention have conducted extensive studies to solve the above problems, and as a result, novel 4,5-
The inventors have found a method for synthesizing dihalogeno-6- (α-substituted ethyl) pyrimidine and completed the present invention. That is,
The present invention is as follows. The first invention is represented by the following formula (I):

【0005】[0005]

【化6】 [Chemical 6]

【0006】(式中、Rは低級アシルオキシ基又は水酸
基を表す。)で示される4,5−ジハロゲノ−6−(α
−置換エチル)ピリミジンに関するものである。第2の
発明は、次式(II):
(In the formula, R represents a lower acyloxy group or a hydroxyl group), and 4,5-dihalogeno-6- (α
-Substituted ethyl) pyrimidine. The second invention is represented by the following formula (II):

【0007】[0007]

【化7】 [Chemical 7]

【0008】で示されるピリミジン化合物と次式(II
I):
A pyrimidine compound represented by the following formula (II)
I):

【0009】[0009]

【化8】 [Chemical 8]

【0010】(式中、R’は低級アルキル基を表す。)
で示される低級脂肪族カルボン酸類とを反応させること
を特徴とする前記記載の式(I)においてRが低級アシ
ルオキシ基で表されるピリミジン化合物の製法に関する
ものである。第3の発明は、次式(I−1):
(In the formula, R'represents a lower alkyl group.)
The present invention relates to a process for producing a pyrimidine compound represented by the above formula (I), wherein R represents a lower acyloxy group, which is characterized by reacting with a lower aliphatic carboxylic acid represented by The third invention is the following formula (I-1):

【0011】[0011]

【化9】 [Chemical 9]

【0012】(式中、R’は前記の記載と同義であ
る。)で示されるピリミジン化合物と次式(IV):
(Wherein R'is as defined above) and a pyrimidine compound represented by the following formula (IV):

【0013】[0013]

【化10】 [Chemical 10]

【0014】(式中、Mはアルカリ金属を表す。)で示
される無機塩類とを反応させることを特徴とする前記記
載の式(I)においてRが水酸基で表されるピリミジン
化合物の製法に関するものである。以下、本発明につい
て詳細に説明する。前記の目的化合物である新規な4,
5−ジハロゲノ−6−(α−置換エチル)ピリミジン
〔化合物(I){化合物(I−1),化合物(I−
2)}〕,その製造原料〔化合物(II),化合物(I
II),無機塩類〕におけるR,R’及びMは次の通り
である。
A method for producing a pyrimidine compound represented by the above formula (I), wherein R represents a hydroxyl group, characterized by reacting with an inorganic salt represented by the formula (M represents an alkali metal) Is. Hereinafter, the present invention will be described in detail. The novel 4, which is the above-mentioned target compound
5-dihalogeno-6- (α-substituted ethyl) pyrimidine [compound (I) {compound (I-1), compound (I-
2)}], its raw material [compound (II), compound (I
II), inorganic salts], R, R'and M are as follows.

【0015】Rとしては、低級アシルオキシ基,水酸基
を挙げることができる。Rにおける低級アシルオキシ基
としては、好ましくは炭素原子数が1〜4個の直鎖状又
は分岐状のもの(例えば、アセチルオキシ基,n−プロ
ピオニルオキシ基,i−プロピオニルオキシ基,n−ブ
チロイルオキシ基,i−ブチロイルオキシ基,t−ブチ
ロイルオキシ基など)がよく、さらに好ましくはアセチ
ルオキシ基がよい。Mはアルカリ金属を表す。
Examples of R include a lower acyloxy group and a hydroxyl group. The lower acyloxy group in R is preferably a linear or branched one having 1 to 4 carbon atoms (eg, acetyloxy group, n-propionyloxy group, i-propionyloxy group, n-butyroyloxy group). , I-butyroyloxy group, t-butyroyloxy group, etc.), and more preferably acetyloxy group. M represents an alkali metal.

【0016】本発明の化合物(I)の合成は、次に示す
合成法1又は2によって行うことができる。 (合成法1)化合物(I)においてRが低級アシルオキ
シ基で表される4,5−ジハロゲノ−6−(α−低級ア
シルオキシエチル)ピリミジン〔化合物(I−1)〕の
合成は、次に示すように、化合物(II)と化合物(I
II)とを溶媒中又は無溶媒で反応させることによって
行うことができるが;好ましくは塩基存在下、溶媒中で
反応させるのがよい。
The compound (I) of the present invention can be synthesized by the following synthetic method 1 or 2. (Synthesis Method 1) Synthesis of 4,5-dihalogeno-6- (α-lower acyloxyethyl) pyrimidine [Compound (I-1)] in which R is a lower acyloxy group in Compound (I) is shown below. Thus, compound (II) and compound (I
It can be carried out by reacting with II) in a solvent or without a solvent; it is preferable to react in a solvent in the presence of a base.

【0017】[0017]

【化11】 [Chemical 11]

【0018】(式中、R’は前記の記載と同義であ
る。)溶媒としては、本反応に直接関与しないものであ
れば特に限定されず、例えば、ベンゼン,トルエン,キ
シレン,メチルナフタリン,石油エーテル,リグロイ
ン,ヘキサン,クロルベンゼン,ジクロルベンゼン,塩
化メチレン,クロロホルム,ジクロルエタン,トリクロ
ルエチレンのような塩素化された又はされていない芳香
族,脂肪族,脂環式の炭化水素類;ジエチルエーテル,
テトラヒドロフラン,ジオキサンなどのようなエーテル
類;アセトン,メチルエチルケトンなどのようなケトン
類;N,N−ジメチルホルムアミド,N,N−ジメチル
アセトアミドなどのようなアミド類;アセトニトリル,
プロピオニトリルなどのようなニトリル類;トリエチル
アミン,ピリジン,N,N−ジメチルアニリンなどのよ
うな有機塩基類;1,3−ジメチル−2−イミダゾリノ
ン;ジメチルスルホキシド;酢酸,プロピオン酸などの
ような脂肪族カルボン酸;前記溶媒の混合物などを挙げ
ることができる。
(In the formula, R'has the same meaning as described above.) The solvent is not particularly limited as long as it does not directly participate in the reaction, and examples thereof include benzene, toluene, xylene, methylnaphthalene and petroleum. Chlorinated or unchlorinated aromatic, aliphatic or alicyclic hydrocarbons such as ether, ligroin, hexane, chlorobenzene, dichlorobenzene, methylene chloride, chloroform, dichloroethane, trichloroethylene; diethyl ether,
Ethers such as tetrahydrofuran, dioxane; ketones such as acetone, methyl ethyl ketone; amides such as N, N-dimethylformamide, N, N-dimethylacetamide; acetonitrile,
Nitriles such as propionitrile; organic bases such as triethylamine, pyridine, N, N-dimethylaniline; 1,3-dimethyl-2-imidazolinone; dimethyl sulfoxide; acetic acid, propionic acid, etc. Aliphatic carboxylic acids; a mixture of the above solvents, and the like can be mentioned.

【0019】前記の溶媒のうちでも、好ましくはN,N
−ジメチルホルムアミド又は導入するアシルオキシ基と
同一の脂肪族カルボン酸を用いるのがよい。溶媒の使用
量は、化合物(II)の濃度が5〜80重量%の濃度範
囲になるようにして使用することができるが、好ましく
は化合物(II)の膿度が10〜50重量%になるよう
にして使用するのがよい。
Of the above solvents, N, N are preferred.
-It is preferable to use dimethylformamide or the same aliphatic carboxylic acid as the acyloxy group to be introduced. The amount of the solvent used may be such that the concentration of the compound (II) is in the concentration range of 5 to 80% by weight, but the pus degree of the compound (II) is preferably 10 to 50% by weight. It is good to use in this way.

【0020】塩基としては、特に限定されず、例えば、
有機塩基(例えば、トリエチルアミン,ピリジン,N,
N−ジメチルアニリン,DBUなど)、無機塩基(例え
ば、水素化ナトリウム,ナトリウムアミド,水酸化ナト
リウム,水酸化カリウム,炭酸水素ナトリウム,炭酸ナ
トリウム,炭酸カリウムなど)を挙げることができる
が;好ましくは無機塩基がよい。塩基の使用量は、化合
物(II)に対して1〜5倍モルで使用することができ
るが、好ましくは1.2〜2倍モルがよい。
The base is not particularly limited and includes, for example,
Organic bases (eg triethylamine, pyridine, N,
N-dimethylaniline, DBU, etc.) and inorganic bases (eg, sodium hydride, sodium amide, sodium hydroxide, potassium hydroxide, sodium hydrogencarbonate, sodium carbonate, potassium carbonate, etc.) can be mentioned; A good base. The amount of the base used can be 1 to 5 times the molar amount of the compound (II), but preferably 1.2 to 2 times the molar amount.

【0021】反応温度は、特に限定されないが、室温か
ら使用する溶媒の沸点以下の温度範囲内であり、40℃
〜80℃が好ましい。反応時間は、前記の濃度,温度に
よって変化するが、通常1〜10時間で行うことができ
る。
The reaction temperature is not particularly limited, but is within a temperature range from room temperature to the boiling point of the solvent to be used, 40 ° C.
-80 degreeC is preferable. The reaction time varies depending on the above-mentioned concentration and temperature, but can be usually 1 to 10 hours.

【0022】以上のようにして製造された目的の化合物
(I−1)は、反応終了後、抽出,濃縮,濾過などの通
常の後処理を行い、必要に応じて再結晶,各種クロマト
グラフィーなどの公知の手段で適宜精製することができ
る。化合物(I−1)としては、例えば、次の表1中に
示した各化合物(I)〔例えば、化合物1〜3などを挙
げることができる。そして、化合物1とは、化合物
(I)で示される式におけるRが−OCOCHである
ことを意味する。〕を挙げることができる。
The desired compound (I-1) produced as described above is subjected to usual post-treatments such as extraction, concentration and filtration after the completion of the reaction, and if necessary, recrystallization, various chromatographies and the like. It can be appropriately purified by a known method. Examples of the compound (I-1) include the compounds (I) shown in Table 1 below [for example, compounds 1 to 3 and the like. And the compound 1 means that R in the formula represented by the compound (I) is -OCOCH 3 . ] Can be mentioned.

【0023】[0023]

【表1】 [Table 1]

【0024】(合成法2)化合物(I)においてRが水
酸基で表される4,5−ジハロゲノ−6−(α−ヒドロ
キシエチル)ピリミジン〔化合物(I−2)〕の合成
は、次に示すように、化合物(I−1)と無機塩類〔化
合物(IV)〕とを溶媒中で反応させることによって行
うことができる。
(Synthesis Method 2) Synthesis of 4,5-dihalogeno-6- (α-hydroxyethyl) pyrimidine [Compound (I-2)] in which R is a hydroxyl group in Compound (I) is shown below. Thus, the compound (I-1) and the inorganic salt [compound (IV)] can be reacted in a solvent.

【0025】[0025]

【化12】 [Chemical formula 12]

【0026】(式中、R’及びMは前記の記載と同義で
ある。)溶媒としては、本反応に直接関与しないもので
あれば特に限定されず、例えば、合成法1に記載したエ
ーテル類,ケトン類,アミド類などの溶媒;アルコール
類(例えば、メタノール,エタノール,プロパノール,
ブタノールなど);水;前記溶媒の混合物などを挙げる
ことができる。
(In the formula, R ′ and M have the same meanings as described above.) The solvent is not particularly limited as long as it does not directly participate in this reaction, and for example, the ethers described in Synthesis Method 1 , Solvents such as ketones and amides; alcohols (eg, methanol, ethanol, propanol,
Butanol, etc.); water; a mixture of the above solvents, and the like.

【0027】前記の溶媒のうちでも、好ましくはテトラ
ヒドロフラン,ジオキサンなどのようなエーテル類と水
との混合物がよい。溶媒の使用量は、化合物(I−1)
の濃度が5〜80重量%の濃度範囲になるようにして使
用することができるが、好ましくは化合物(I−1)の
濃度が10〜70重量%になるようにして使用するのが
よい。
Among the above solvents, a mixture of ethers such as tetrahydrofuran and dioxane and water is preferable. The amount of the solvent used is the compound (I-1)
The compound (I-1) can be used in a concentration range of 5 to 80% by weight, preferably the compound (I-1) concentration is 10 to 70% by weight.

【0028】無機塩類〔化合物(IV)〕としては、例
えば、合成法1に記載の無機塩基を挙げることができる
が;好ましくは水酸化ナトリウム,水酸化カリウムがよ
い。無機塩基の使用量は、化合物(I−1)に対して1
〜5倍モルで使用することができるが、好ましくは2〜
5倍モルがよい。
Examples of the inorganic salts [compound (IV)] include the inorganic bases described in Synthesis Method 1; sodium hydroxide and potassium hydroxide are preferable. The amount of the inorganic base used is 1 with respect to the compound (I-1).
~ 5 times the molar amount can be used, but preferably 2 ~
5 times mole is good.

【0029】反応温度は、特に限定されないが、室温か
ら使用する溶媒の沸点以下の温度範囲内であり、室温〜
50℃が好ましい。反応時間は、前記の濃度,温度によ
って変化するが、通常0.5〜1時間で行うことができ
る。以上のようにして製造された目的の化合物(I−
2)は、反応終了後、抽出,濃縮,濾過などの通常の後
処理を行い、必要に応じて再結晶,各種クロマトグラフ
ィーなどの公知の手段で適宜精製することができる。化
合物(I−2)の物性を前記の表1中に示す。
The reaction temperature is not particularly limited, but it is within the temperature range from room temperature to the boiling point of the solvent to be used, or from room temperature to
50 ° C is preferred. The reaction time varies depending on the above-mentioned concentration and temperature, but can usually be 0.5 to 1 hour. The desired compound (I-
After completion of the reaction, 2) can be subjected to usual post-treatments such as extraction, concentration, filtration, etc., and if necessary, can be appropriately purified by a known means such as recrystallization or various chromatography. The physical properties of the compound (I-2) are shown in Table 1 above.

【0030】このようにして得られた化合物(I)は、
例えば、次に示すように、特願平3−354223号に
記載されたような優れた殺虫・殺ダニ・殺菌活性を有す
るアラルキルアミノピリミジン誘導体の合成原料として
有用なものである。
The compound (I) thus obtained is
For example, as shown below, it is useful as a raw material for synthesizing an aralkylaminopyrimidine derivative having excellent insecticidal, acaricidal and bactericidal activity as described in Japanese Patent Application No. 3-354223.

【0031】[0031]

【化13】 [Chemical 13]

【0032】(式中、Rは前記の記載と同義であり;R
は水素原子,アルキル基を表し;Rは低級ハロアル
コキシ基,水素原子,低級アルキル基,低級アルコキシ
基,低級ハロアルキル基,ニトロ基又はハロゲン原子を
表し;nは1〜5の整数を表す。)
(Wherein R has the same meaning as described above; R
1 represents a hydrogen atom or an alkyl group; R 2 represents a lower haloalkoxy group, a hydrogen atom, a lower alkyl group, a lower alkoxy group, a lower haloalkyl group, a nitro group or a halogen atom; and n represents an integer of 1 to 5. .. )

【0033】[0033]

【実施例】以下、本発明を実施例によって具体的に説明
する。なお、これらの実施例は、本発明の範囲を限定す
るものではない。 参考例1〔化合物(II)の合成〕 6−(α−クロロエチル)−4,5−ジクロロピリミジ
ンの合成 4,5−ジクロロ−6−エチルピリミジン(270g)
をジクロロメタン(750ml)に溶解し、30〜35
℃に加温、攪拌下に塩素ガスを2時間吹き込んだ。反応
終了後、反応液に窒素ガスを吹き込み、過剰に溶存する
塩素ガスを除いた。次いで、減圧下にジクロロメタンを
留去し、得られた油状物を減圧蒸留することによって淡
黄色の液体である目的物を240g得た。
EXAMPLES The present invention will be specifically described below with reference to examples. It should be noted that these examples do not limit the scope of the present invention. Reference Example 1 [Synthesis of Compound (II)] Synthesis of 6- (α-chloroethyl) -4,5-dichloropyrimidine 4,5-Dichloro-6-ethylpyrimidine (270 g)
Is dissolved in dichloromethane (750 ml), 30-35
Chlorine gas was blown in for 2 hours while being heated to ℃ and stirred. After completion of the reaction, nitrogen gas was blown into the reaction solution to remove excessive dissolved chlorine gas. Then, dichloromethane was distilled off under reduced pressure, and the obtained oily substance was distilled under reduced pressure to obtain 240 g of a target product which was a pale yellow liquid.

【0034】(物性) ・b.p.110〜113℃/7mmHg ・H−NMR(CDCl) δppm 1.90(d,3H)、5.50(q,1H)、8.9
0(s,1H)
(Physical properties) b. p. 110~113 ℃ / 7mmHg · 1 H- NMR (CDCl 3) δppm 1.90 (d, 3H), 5.50 (q, 1H), 8.9
0 (s, 1H)

【0035】実施例1〔化合物(1)の合成〕 (1)6−(α−アセトキシエチル)−4,5−ジクロ
ロピリミジン(化合物1)の合成 4,5−ジクロロ−6−エチルピリミジン(10.2
g)をN,N−ジメチルホルムアミド(150ml)に
溶解し、酢酸カリウム(12.0g)と炭酸カリウム
(3.0g)を加え、約60℃で3時間攪拌した。反応
液に水(200ml)を加え、分離する油状物をトルエ
ンで抽出し、水洗後、無水硫酸ナトリウムで乾燥した。
次いで、減圧下に溶媒を留去し、得られた残渣をカラム
クロマトグラフィー(ワコーゲルC−200、トルエ
ン:酢酸エチル=10:1溶出)で精製することによっ
て、淡黄色の液体である目的物を5.2g得た。
Example 1 [Synthesis of Compound (1)] (1) Synthesis of 6- (α-acetoxyethyl) -4,5-dichloropyrimidine (Compound 1) 4,5-Dichloro-6-ethylpyrimidine (10) .2
g) was dissolved in N, N-dimethylformamide (150 ml), potassium acetate (12.0 g) and potassium carbonate (3.0 g) were added, and the mixture was stirred at about 60 ° C. for 3 hr. Water (200 ml) was added to the reaction solution, the separated oily substance was extracted with toluene, washed with water, and dried over anhydrous sodium sulfate.
Then, the solvent was distilled off under reduced pressure, and the obtained residue was purified by column chromatography (Wakogel C-200, toluene: ethyl acetate = 10: 1 elution) to give the desired product as a pale yellow liquid. Obtained 5.2 g.

【0036】(物性) ・H−NMR(CDCl) δppm 1.55〜1.62(d,3H)、2.15(s,3
H)、6.00〜6.12(q,1H)、8.84
(s,1H)
(Physical properties) 1 H-NMR (CDCl 3 ) δppm 1.55 to 1.62 (d, 3H), 2.15 (s, 3)
H), 6.00 to 6.12 (q, 1H), 8.84
(S, 1H)

【0037】(2)4,5−ジクロロ−6−(α−ヒド
ロキシエチル)ピリミジン(化合物4)の合成 6−(α−アセトキシエチル)−4,5−ジクロロピリ
ミジン(4.0g)をテトラヒドロフラン(50ml)
に溶解し、攪拌下に1N−水酸化ナトリウム水溶液(3
0ml)をゆっくりと滴下した。滴下後、更に1時間室
温で攪拌し、反応を完結した。次いで、減圧下に溶媒を
留去し、得られた残渣をカラムクロマトグラフィー(ワ
コーゲルC−200、トルエン:酢酸エチル=5:1溶
出)で精製することによって、淡黄色の液体である目的
物を2.8g得た。
(2) Synthesis of 4,5-dichloro-6- (α-hydroxyethyl) pyrimidine (Compound 4) 6- (α-acetoxyethyl) -4,5-dichloropyrimidine (4.0 g) was added to tetrahydrofuran ( 50 ml)
Dissolved in 1N-sodium hydroxide aqueous solution (3
0 ml) was slowly added dropwise. After the dropping, the reaction was completed by further stirring for 1 hour at room temperature. Then, the solvent was distilled off under reduced pressure, and the obtained residue was purified by column chromatography (Wakogel C-200, toluene: ethyl acetate = 5: 1 elution) to give the desired product as a pale yellow liquid. 2.8 g was obtained.

【0038】(物性) ・H−NMR(CDCl) δppm 1.47〜1.52(d,3H)、3.76〜3.85
(d,1H)、5.17〜5.25(m,1H)、8.
88(s,1H)
(Physical properties) 1 H-NMR (CDCl 3 ) δppm 1.47 to 1.52 (d, 3H), 3.76 to 3.85
(D, 1H), 5.17 to 5.25 (m, 1H), 8.
88 (s, 1H)

【0039】(3)表1中のその他の化合物の合成 前記(1)に記載の方法に準じて、表1中に記載したよ
うな4,5−ジハロゲノ−6−(α−低級アシルオキシ
エチル)ピリミジンを合成した。
(3) Synthesis of Other Compounds in Table 1 According to the method described in (1) above, 4,5-dihalogeno-6- (α-lower acyloxyethyl) as described in Table 1 Pyrimidine was synthesized.

【0040】[0040]

【発明の効果】本発明の新規な4,5−ジハロゲノ−6
−(α−置換エチル)ピリミジンは、医農薬などの合成
中間体として有用である。
The novel 4,5-dihalogeno-6 of the present invention
-(Α-Substituted ethyl) pyrimidine is useful as a synthetic intermediate for medicines and agricultural chemicals.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 次式: 【化1】 (式中、Rは低級アシルオキシ基又は水酸基を表す。)
で示される4,5−ジハロゲノ−6−(α−置換エチ
ル)ピリミジン。
1. The following formula: (In the formula, R represents a lower acyloxy group or a hydroxyl group.)
The 4,5-dihalogeno-6- (α-substituted ethyl) pyrimidine represented by:
【請求項2】 次式: 【化2】 で示されるピリミジン化合物と次式: 【化3】 (式中、R’は低級アルキル基を表す。)で示される低
級脂肪族カルボン酸類とを反応させることを特徴とする
請求項1記載の式(I)においてRが低級アシルオキシ
基で表されるピリミジン化合物の製法。
2. The following formula: And a pyrimidine compound represented by the following formula: (In the formula, R'represents a lower alkyl group.) A lower aliphatic carboxylic acid represented by the formula (I) is reacted with R in the formula (I). Process for producing pyrimidine compound.
【請求項3】 次式: 【化4】 (式中、R’は請求項1の記載と同義である。)で示さ
れるピリミジン化合物と次式: 【化5】 (式中、Mはアルカリ金属を表す。)で示される無機塩
類とを反応させることを特徴とする請求項1記載の式
(I)においてRが水酸基で表されるピリミジン化合物
の製法。
3. The following formula: (In the formula, R ′ has the same meaning as described in claim 1.) and a pyrimidine compound represented by the following formula: (In the formula, M represents an alkali metal.) An inorganic salt represented by the formula is reacted to produce a pyrimidine compound represented by formula (I) in which R is a hydroxyl group.
JP16528692A 1992-05-15 1992-05-15 4,5-Dihalogeno-6- (α-substituted ethyl) pyrimidine and process for producing the same Expired - Fee Related JP2649122B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16528692A JP2649122B2 (en) 1992-05-15 1992-05-15 4,5-Dihalogeno-6- (α-substituted ethyl) pyrimidine and process for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16528692A JP2649122B2 (en) 1992-05-15 1992-05-15 4,5-Dihalogeno-6- (α-substituted ethyl) pyrimidine and process for producing the same

Publications (2)

Publication Number Publication Date
JPH05320141A true JPH05320141A (en) 1993-12-03
JP2649122B2 JP2649122B2 (en) 1997-09-03

Family

ID=15809444

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16528692A Expired - Fee Related JP2649122B2 (en) 1992-05-15 1992-05-15 4,5-Dihalogeno-6- (α-substituted ethyl) pyrimidine and process for producing the same

Country Status (1)

Country Link
JP (1) JP2649122B2 (en)

Also Published As

Publication number Publication date
JP2649122B2 (en) 1997-09-03

Similar Documents

Publication Publication Date Title
JP2649122B2 (en) 4,5-Dihalogeno-6- (α-substituted ethyl) pyrimidine and process for producing the same
AU2006240772B2 (en) Method for producing nicotinic acid derivative or salt thereof
JP2851524B2 (en) Method for producing sulfonylurea derivative
JP4026233B2 (en) Method for producing 4,5-dichloro-6- (α-fluoroalkyl) pyrimidine
US6340757B1 (en) 6-(1-fluoroalkyl)-4-pyrimidones and processes for producing the same
JP4568404B2 (en) Method for producing pyrazole carboxylic acid ester derivative
JP2003335731A (en) New carboxylic acid anhydride and method for synthesizing ester and lactone using the same
JP2003212861A (en) Method for producing pyrimidinyl alcohol derivative and synthetic intermediate thereof
US5514811A (en) Process for synthesizing 4-halo-5-(hydroxymethyl) imidazole compounds
JP4055246B2 (en) 5-chloro-6- (α-fluoroalkyl) -4-pyrimidone and process for producing the same
JP2879164B2 (en) Method for producing substituted 2-cyanoimidazole compounds
JP4538993B2 (en) Process for producing β-ketonitrile derivatives
JP3887893B2 (en) Process for producing 4- [2- (4- (trifluoromethoxy) phenyl) ethylamino] pyrimidine derivative, production intermediate and process for producing the same
JP4110633B2 (en) 3-Amino-4-fluoro-2-unsaturated carboxylic acid ester and process for producing the same
US5286861A (en) Process for preparing uracil derivatives
JP2007070270A (en) Manufacturing method of 3-aminomethyloxetane compound
JPH10130246A (en) Pyrimidine compound and production thereof
JP4123609B2 (en) Process for producing 6- (α-fluoroalkyl) -4-pyrimidone
JP3527255B2 (en) 6-N-substituted aminopicolinic acid derivatives and their production
JP4561635B2 (en) Process for producing 4-alkoxycarbonyltetrahydropyran or tetrahydropyranyl-4-carboxylic acid
JP2002187883A (en) 6-(1-fluoroethyl)-5-iodo-4-pyrimidone and method of preparing the same
JPH05194417A (en) 4,5-dihalogeno-6-@(3754/24)alpha-halogenoethyl)pyrimidine and its production
JP3536648B2 (en) 6- (α-fluoroalkyl) -4-pyrimidone and method for producing the same
JP2003089691A (en) 6-(1-fluoroethyl)pyrimidine compound and method for producing the same
JPH0710831A (en) Production of acrylate based compound and synthetic intermediate therefor

Legal Events

Date Code Title Description
FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 12

Free format text: PAYMENT UNTIL: 20090516

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090516

Year of fee payment: 12

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 13

Free format text: PAYMENT UNTIL: 20100516

LAPS Cancellation because of no payment of annual fees